Back
German American Bancorp Vs. Corcept Therapeutics Industry Stock Comparison
Sell
29
GABC
German American Bancorp
Last Price:
40.67
Seasonality Move:
4.61%
Buy
74
CORT
Corcept Therapeutics
Last Price:
40.92
Seasonality Move:
-0.77%
Sell
29
German American Bancorp (GABC)
is a Sell
Is German American Bancorp a Buy, Sell or Hold?
- The current German American Bancorp [GABC] share price is $40.69. The Score for GABC is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- GABC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $40.92. The Score for CORT is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GABC Stock Price Chart
What is German American Bancorp's stock price today?
-
The German American Bancorp share price today is $40.69
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GABC is experiencing buying pressure, which is a positive indicator for future bullish movement.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $40.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing selling pressure, which indicates risk of future bearish movement.
GABC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 64.94 | Buy |
| Chaikin Money Flow: | 82009 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.46 - 39.92) | Buy |
| Bollinger Bands (100): | (32.63 - 39.15) | Buy |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.55 | Buy |
| Relative Strength Index (14 RSI): | 72.34 | Buy |
| Chaikin Money Flow: | -986948 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.51 - 37.97) | Buy |
| Bollinger Bands (100): | (28.35 - 36.03) | Buy |
GABC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.23 | Buy |
| 20-day SMA: | 39.37 | Buy |
| 50-day SMA: | 38.93 | Buy |
| 200-day SMA: | 34.17 | Buy |
| 8-day EMA: | 39.54 | Buy |
| 20-day EMA: | 39.19 | Buy |
| 50-day EMA: | 38.24 | Buy |
| 200-day EMA: | 34.81 | Buy |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.22 | Buy |
| 20-day SMA: | 36.07 | Buy |
| 50-day SMA: | 35.08 | Buy |
| 200-day SMA: | 28.51 | Buy |
| 8-day EMA: | 38.83 | Buy |
| 20-day EMA: | 36.86 | Buy |
| 50-day EMA: | 34.93 | Buy |
| 200-day EMA: | 30.16 | Buy |
German American Bancorp Earnings Growth & GABC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.12 per share, a decrease this year of $0.12 per share, and an increase next year of $0.41 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.15 per share, an increase this year of $0.22 per share, and an increase next year of $0.59 per share.
German American Bancorp Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||